AI Verdict
GMED has stronger fundamentals based on our AI analysis.
GNRC vs GMED Fundamental Comparison
| Metric | GNRC | GMED |
|---|---|---|
| Revenue | $4.2B | $2.9B |
| Net Income | $159.6M | $537.9M |
| Net Margin | 3.8% | 18.3% |
| ROE | 6.1% | 11.8% |
| ROA | 2.9% | 10.1% |
| Current Ratio | 2.03x | 4.26x |
| Debt/Equity | 0.45x | 0.00x |
| EPS | $2.69 | $3.92 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GNRC vs GMED: Frequently Asked Questions
Is GNRC or GMED a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GMED has stronger fundamentals. GNRC is rated SELL (66% confidence) while GMED is rated BUY (78% confidence). This is not investment advice.
How does GNRC compare to GMED fundamentally?
GENERAC HOLDINGS INC. has ROE of 6.1% vs GLOBUS MEDICAL INC's 11.8%. Net margins are 3.8% vs 18.3% respectively.
Which stock pays higher dividends, GNRC or GMED?
GNRC has a dividend yield of N/A or no dividend while GMED has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GNRC or GMED for long term?
For long-term investing, consider that GNRC has SELL rating with 66% confidence, while GMED has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GNRC vs GMED?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GNRC vs GMED, the AI consensus favors GMED based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.